| Descriptor English: | Amlodipine Besylate, Olmesartan Medoxomil Drug Combination | ||||
| Descriptor Spanish: |
Combinación Besilato de Amlodipino y Olmesartán Medoxomilo
| ||||
| Descriptor Portuguese: | Combinação Besilato de Anlodipino e Olmesartana Medoxomila | ||||
| Descriptor French: | Association de bésilate d'amlodipine et d'olmésartan médoxomil | ||||
| Entry term(s): |
Amlodipine Besylate Olmesartan Medoxomil Amlodipine Besylate Olmesartan Medoxomil Drug Combination Amlodipine Besylate, Olmesartan Medoxomil Amlodipine Besylate-Olmesartan Medoxomil Amlodipine Besylate-Olmesartan Medoxomil Drug Combination Azor Besylate-Olmesartan Medoxomil, Amlodipine Medoxomil, Amlodipine Besylate-Olmesartan |
||||
| Tree number(s): |
D03.383.129.308.674.500 D03.383.129.617.584.500 D03.383.725.203.065.500 D26.310.063 |
||||
| RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D000068558 | ||||
| Scope note: | A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION. |
||||
| Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
| Pharm Action: |
Antihypertensive Agents Calcium Channel Blockers Angiotensin II Type 1 Receptor Blockers |
||||
| Previous Indexing: |
Amlodipine (2010-2015) Antihypertensive Agents (2012-2015) |
||||
| Public MeSH Note: | 2016 |
||||
| History Note: | 2016 |
||||
| DeCS ID: | 55915 | ||||
| Unique ID: | D000068558 | ||||
| Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
| Date Established: | 2016/01/01 | ||||
| Date of Entry: | 2015/07/01 | ||||
| Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Pharmaceutical Preparations [D26]Pharmaceutical Preparations
|
|
Amlodipine Besylate, Olmesartan Medoxomil Drug Combination
- Preferred
Azor
- Narrower
| Concept UI |
M000603113 |
| Scope note | A pharmaceutical preparation of amlodipine besylate and olmesartan medoxomil that combines ANGIOTENSIN II TYPE I RECEPTOR ANTAGONIST and CALCIUM CHANNEL BLOCKER activities. It is used in the management of HYPERTENSION. |
| Preferred term | Amlodipine Besylate, Olmesartan Medoxomil Drug Combination |
| Entry term(s) |
Amlodipine Besylate Olmesartan Medoxomil Amlodipine Besylate Olmesartan Medoxomil Drug Combination Amlodipine Besylate, Olmesartan Medoxomil Amlodipine Besylate-Olmesartan Medoxomil Amlodipine Besylate-Olmesartan Medoxomil Drug Combination Besylate-Olmesartan Medoxomil, Amlodipine Medoxomil, Amlodipine Besylate-Olmesartan |
| Concept UI |
M000603407 |
| Preferred term | Azor |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey
